美能专区当前位置：首页> 美能专区 >
产品档案更多>>
Eisai Inc
Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Established in 1995, Eisai Inc. be
公司档案更多>>
产品要闻更多>>
第三届地坛国际感染会 
“卫材新军 护肝美能”第一届专家顾问会
复方甘草酸苷
更多
- Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C
- APASL2006中文版
- PROSPECTIVE ASSESSMENT OF THE INCIDENCE OF INFECTIONS DURING PEGYLATED INTERFERO
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis
- Glycyrrhizin in Chronic Hepatitis C Patients
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic
- Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic
- Randomized clinical trial with SNMC in Chin-BE Wang-ok
- The long term efficacy of glycyrrhizin in chronic hepatitis C patients
- Hepatitis C viral infection
